This randomized open-label trial compared the efficacy and tolerability of vortioxetine (15 mg/daily) with different antidepressants in the treatment of patients with Burning Mouth Syndrome (BMS).
Vortioxetine versus other antidepressants in the treatment of Burning Mouth Syndrome: an open-label randomized trial
Coppola, Noemi;Calabria, Elena
;Aria, Massimo;Mignogna, Michele Davide
2021
Abstract
This randomized open-label trial compared the efficacy and tolerability of vortioxetine (15 mg/daily) with different antidepressants in the treatment of patients with Burning Mouth Syndrome (BMS).File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
